Information for Victims in Large Cases
U.S. v. Glenmark Pharmaceuticals Inc., USA
Glenmark Pharmaceuticals Inc., USA is charged with knowingly entering into and engaging in a conspiracy to suppress and eliminate competition by agreeing to increase and maintain prices of pravastatin and other generic drugs sold in the United States. The charged conspiracy began at least as early as May 2013 and continued at least until December 2015.
U.S. v. Hector Armando Kellum
Hector Armando Kellum was charged with participating in a conspiracy to suppress and eliminate competition by agreeing to allocate customers and rig bids for, and stabilize, maintain, and fix prices of, generic drugs sold in the United States from at least as early as March 2013 until at least June 2015.
U.S. v. Kemp & Associates, Inc. and Daniel J. Mannix
Kemp & Associates, Inc. and Daniel J. Mannix were charged with engaging in a conspiracy to allocate customers of heir location services sold in the United States beginning as early as September 1999 and continuing as late as January 29, 2014 , which resulted in sales of heir location services at collusive and noncompetitive contingency fee rates.